These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

703 related articles for article (PubMed ID: 19403023)

  • 21. Clinical and laboratory predictors of esophageal varices in children and adolescents with portal hypertension syndrome.
    Fagundes ED; Ferreira AR; Roquete ML; Penna FJ; Goulart EM; Figueiredo Filho PP; Bittencourt PF; Carvalho SD; Albuquerque W
    J Pediatr Gastroenterol Nutr; 2008 Feb; 46(2):178-83. PubMed ID: 18223377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic indicators of survival in patients with cirrhosis and esophageal varices, without previous bleeding.
    Merkel C; Bolognesi M; Angeli P; Noventa F; Caregaro L; Sacerdoti D; Gatta A
    Am J Gastroenterol; 1989 Jul; 84(7):717-22. PubMed ID: 2787099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparison of the Model for End-stage Liver Disease and hepatic venous pressure gradient for predicting survival in patients with decompensated liver cirrhosis].
    Lee SH; Park SH; Kim GW; Lee WJ; Hong WK; Ryu MS; Park KT; Lee MY; Lee CW; Kim JH; Kim YM; Kim SJ; Baik GH; Kim JB; Kim DJ
    Korean J Hepatol; 2009 Sep; 15(3):350-6. PubMed ID: 19783884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Portal hypertension.
    Garcia-Tsao G
    Curr Opin Gastroenterol; 2006 May; 22(3):254-62. PubMed ID: 16550040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of variceal bleed among patients with liver cirrhosis in the era of sclerotherapy.
    Varghese J; Cherian JV; Solomon R; Jayanthi V
    Singapore Med J; 2008 Mar; 49(3):239-42. PubMed ID: 18363007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New concepts on the clinical course and stratification of compensated and decompensated cirrhosis.
    D'Amico G; Morabito A; D'Amico M; Pasta L; Malizia G; Rebora P; Valsecchi MG
    Hepatol Int; 2018 Feb; 12(Suppl 1):34-43. PubMed ID: 28681347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Independent prognostic factors in patients with liver cirrhosis.
    Piekarska A; Zboinska J; Szymczak W; Kuydowicz J
    Hepatogastroenterology; 2008; 55(84):1034-40. PubMed ID: 18705324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score.
    Huo TI; Wu JC; Lin HC; Lee FY; Hou MC; Lee PC; Chang FY; Lee SD
    J Hepatol; 2005 Jun; 42(6):826-32. PubMed ID: 15885353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Serum sodium concentration profile for cirrhotic patients and its effect on the prognostic value of the MELD score].
    Zhang JY; Qin CY; Jia JD; Wang BE
    Zhonghua Gan Zang Bing Za Zhi; 2012 Feb; 20(2):108-11. PubMed ID: 22464781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Common complications of cirrhosis: do we follow too often the 'Casablanca strategy'?
    Gundling F; Schmidt T; Schepp W
    Liver Int; 2011 Nov; 31(10):1598-600. PubMed ID: 21745306
    [No Abstract]   [Full Text] [Related]  

  • 31. Model for end-stage liver disease, model for end-stage liver disease-sodium and Child-Turcotte-Pugh scores over time for the prediction of complications of liver cirrhosis.
    Choi PC; Kim HJ; Choi WH; Park DI; Park JH; Cho YK; Sohn CI; Jeon WK; Kim BI
    Liver Int; 2009 Feb; 29(2):221-6. PubMed ID: 18544124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program.
    Garcia-Tsao G; Lim JK;
    Am J Gastroenterol; 2009 Jul; 104(7):1802-29. PubMed ID: 19455106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Viral liver cirrhosis: natural course, pathogenesis and clinical implications of the complications].
    Gentilini P; Laffi G; La Villa G; Casini-Raggi V; Romanelli RG; Buzzelli G; Mazzanti R; Marra F; Pinzani M; Zignego AL
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():23S-29S. PubMed ID: 9004817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Model for end-stage liver disease (MELD) score for predicting late esophageal varices rebleeding in cirrhotic patients.
    Fong TV; Hung FC; Chiu KW; Chiu YC; Wu KL; Kuo CH; Kuo CM
    Hepatogastroenterology; 2008; 55(84):1055-8. PubMed ID: 18705327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can inclusion of serum creatinine values improve the Child-Turcotte-Pugh score and challenge the prognostic yield of the model for end-stage liver disease score in the short-term prognostic assessment of cirrhotic patients?
    Giannini E; Botta F; Fumagalli A; Malfatti F; Testa E; Chiarbonello B; Polegato S; Bellotti M; Milazzo S; Borgonovo G; Testa R
    Liver Int; 2004 Oct; 24(5):465-70. PubMed ID: 15482344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological reduction of portal pressure and long-term risk of first variceal bleeding in patients with cirrhosis.
    Turnes J; Garcia-Pagan JC; Abraldes JG; Hernandez-Guerra M; Dell'Era A; Bosch J
    Am J Gastroenterol; 2006 Mar; 101(3):506-12. PubMed ID: 16542287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural history of compensated viral B and D cirrhosis.
    Gheorghe L; Iacob S; Simionov I; Vadan R; Gheorghe C; Iacob R; Parvulescu I; Constantinescu I
    Rom J Gastroenterol; 2005 Dec; 14(4):329-35. PubMed ID: 16400347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Managing the complications of cirrhosis].
    Deltenre P; Mathurin P; Barraud H; Bronowicki JP; Jacquet E; Puche P; Jaber S; Navarro F; Pageaux GP
    Rev Prat; 2005 Sep; 55(14):1555-63. PubMed ID: 16255297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic factors of survival in complicated viral and alcoholic cirrhosis without hepatocellular carcinoma. A retrospective study.
    Spadaro A; Luigiano C; De Caro G; Morace C; Tortorella V; Bonfiglio C; Pagano N; Consolo P; Alibrandi A; Ajello A; Ferraù O; Freni MA
    Minerva Gastroenterol Dietol; 2007 Dec; 53(4):311-9. PubMed ID: 18043549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of MELD, HVPG, and their changes to predict clinically relevant endpoints in cirrhosis.
    Ripoll C; Lastra P; Rincón D; Catalina V; Bañares R
    Scand J Gastroenterol; 2012 Feb; 47(2):204-11. PubMed ID: 22242615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.